We report the evaluation of a new commercially available assay System for the determination of serum pseudocholinesterase (EC 3.1.1.8) catalytic activity, and its application to a kinetic analyser.
Introduction
The determination of serum pseudocholinesterase (acylcholine acylhydrolase, EC 3.1.1.8) is commonly requested äs a test of hepato^cellular function, to monitor poisoning and excessive exposure to the anticholinesterase organophosphorus insecticides and, ') mainly, for the detection of patients with atypical forms of the enzyme that could react abnormally with succinylcholine (suxamethonium) employed äs a muscle relaxant (l, 2). Indeed, failure of the atypical enzyme to hydrolyze succinylcholine may result in prolonged apnoea in the patient during anaesthesia. Finally, two recent reports (3, 4) have suggested that pseudocholinesterase catalytic activity may be important in the assessment of the risk for cardiovascular disease. Several mcthods have been developed for the determination of pseudocholinesterase. The numerous colorimetric methods (5), using iodide salts of acetyl (6) (7) (8) , propionyl (9) and butyryleholine (8, 10, 11) s Substrates, include the procedure of Ellman (6) in which the Substrates behave similarly to choline esters, and the thiocholine produced by enzymic hydrolysis can be measured by reaction with 5,5'-dithiobis(2-nitrobenzoic acid). In 1977, Okabe et al. (12) described a new totally enzymatic approach to determination of serum pseudocholinesterase catalytic activity by estimating choline derived from benzoylcholine using choline-oxidase and a coupled enzyme System. This paper reports the evaluation of a new commercially available assay System, based on this method, and its application to a kinetic analyser. For reference, we chose the method of Dietz et al. (9) adopted $$ a Selected Method by the American Association for Clinical Chemistry, the method of Garry & Routh (acetylthiocholine s Substrate) (7) and the method of Das & Liddell (butyrylthiocholine s Substrate) (10) . There is no consensus among investigators s to the preferred assay temperature; most determinations have been carried out at 25 °C or 37 °C (13) . The International Federation of Clinical Chemistry has recommended that assay at 30 °C should become the Standard procedure (14) . It therefore seems desirable not only to assess the commercial kit at 30 °C but also to compare the results with those obtained with reference methods at the same temperature (11) .
Materials and Methods

Blood samples
Serum containing the homozygous "atypical" (E* E") enzyme used for this study was obtained from hospital patients who experienced prolonged apnoea vvhen administred succinylcholine in conjunction with surgery. "Heterozygous" (Ey E") and "usual" (E" E") enzymes were obtained from members of families of those individuals demonstrating the "atypical" enzyme and from patients in the Brescia area. Blood was taken from an antecubital vein and allowed to clot; after centrifugation (1000g, 10 min), the unhaemolysed serum was separated and stored at -20 °C until required. Under such conditions of storage, cholinesterase catalytic activity has been shown to be constant for several months (13) .
Measurement of enzyme catalytic activity
The pseudocholinesterase catalytic concentration was expressed in terms of U/l serum (l Unit = l μπιοί of Substrate converted per r minute) measured at 30 °C. All the enzymatic determinations were carried out on Cobas Bio centrifugal analyser (F. Hoffmann La R che and Co., Ltd., Basle, Switzerland). Analyses were performed in triplicate and the mean value was calculated. For the procedures involving the Ellman reaction (6), the enzymatic activity was calculated using 1360 m 2 · mol' 1 s the molar lineic absorbance value for 5-thio-2-nitrobenzoic acid, the product of the reaction.
Propionylthiocholine s substraie
The Selected Method of Dien et al. (9) was used.
Butyrylthiocholine s Substrate
Pseudocholinesterase assay using butyrylthiocholine s Substrate was performed according to the metho 'of Das & Liddell (W).
Acetylthiocholine s Substrate
The method of Garry & Routh (7) was used.
Dibucaine Inhibition
Dibucaine concentrations of 30 μηιοΐ/ΐ were used for the acetyl and propionylthiocholine methods; to achieve a similar Inhibition with butyrylthiocholine s the Substrate, a dibucaine concentration of 54 μηιοΐ/ΐ was needed (2) . For the method under evaluation, the Inhibition curve of pseudocholinesterase by dibucaine was prepared with inhibitor concentrations varying from 30 μπιοΙ/1 to 5.0 irimol/l. The percentage Inhibition was calculated s described previously (9) .
Benzoylcholine s Substrate
The Enzyfast M A 701 Cholinesterase assay kit (product no. 7019) was a gift from Poli Industria Chimica, Milan, Italy. The assay is based on the method of Okabe et al. (12): choline, which is Hberated from benzoylcholine s Substrate by pseudocholinesterase, is oxidized by choline-oxidase (EC 1.1.3.17) to betaine with the simultaneous production of hydrogeri peroxide, which oxidatively couples with 4-aminoantipyrine and phenol in the presence of peroxidase (EC 1.11.1.7) to yield a coloured compound with maximal absorbance at 500 nm. The molar lineic absorbance for the dye formed under these conditions was 689m 2 · mol" 1 .
The kit consists of separate reagents for enzymes and chrom gen, buffer (tris(hydroxymethyl)aminomethane-hydrochloric acid, 0.2 mol/1, pH 7.5) and Substrate. To prepare the working solution, we dissolved the Jyophilized enzymes and a tablet of Substrate in 20 ml of buffer; the final concentrations of the components in the working solution were 1650 U/l choline-oxidase, 3 x 10 7 U/l peroxidase, 0.8 mmol/1 4-aminoantipyrine, 30 mmol/1 phenol and l mmol/1 benzoylcholine Chloride.
Procedure
Cobas Bio was operated according to the usual protocol, the settings being shown in table l, unless otherwise stated. Dibucaine Inhibition studies were performed by the simple Substitution of the reagent containing this material for the usual reagent. 
Results and Discussion
Determination of pseudocholinesterase catalytic adtivity A calibration curve relating serum volume to the hydrolysis of benzoylcholine was prepared, using serum with catalytic concentration of 1978 U/I. The hydrolysis of benzoylcholine was linearly related to the volume of serum up to 3 μΐ ( fig. 1) . Investigation of the effect of incubation time (lag time) on the linearity of the enzymatic reaction showed that the best linearity is obtained with an incubation time of 3 min. 
Reagent stability
The wofking solution is stable for at least six days if stored at 0-4 °C in a dark bottle.
Linearity
Under the described assay conditions, the reaction is linear up to 6500 U/l of serum pseudocholinesterase (ΔA/min = 0.358); samples with values above this were diluted appropiately in saline with no apparent deleterious effects. Interference studies
The addition of various kinds of anticoagulant, such s ethylenediaminetetraacetic acid dipotassium sah, sodium citrate, or lithium heparin had no effect on the evaluated assay method. Sodium fluoride, however, is a known inhibitor of pseudocholinesterase (16) . haematological tests and without clinical evidence of liver diseaser (350 women and 350 men, whose ages ranged from 10 to 65 years). The lower reference limit for males is significantly higher than the value for females (p < 0.001) (fig. 5 ); this sex difference has been observed by other investigators (7, 8) and is probably due to lower values in classes of fertile women (18). Dibucaine Inhibition Figure 6 shows the Inhibition curves of the three pseudocholinesterase phenotype variants s a function of dibucaine concentration. From this figure one can see that the maximum Inhibition differences among the three phenotypes are approximately -3.46 log molar dibucaine concentration, which corresponds to 350 μπκ>1/1 dibucaine concentration.
With this concentration, we reported a mean Inhibition of 78.5% (values ranged from 75 to 82%) for 70 subjects whose sera contained the "usual" enzyme, 68% Inhibition (values ranged from 45 to 72%) for 20 who had "heterozygous" enzyme and 27% (values ranged from 24 to 29%) for 10 who had "atypical" sera. Regression equations from the experimental data of the comparison of dibucaine numbers, obtained with the enzymic and colorimetric procedures, are presented in figures 7, 8 and 9; in all instances, the enzymic method and colorimetric methods appeared to agree. Therefore, with benzoylcholine and dibucaine Inhibition, we could clearly differentiate the genetic variants of pseudocholinesterase; besides, Kalow & Genest (19) first demonstrated the ease with which the "usual" enzyme could be distinguished from the "atypical" and "heterozygous" forms of the enzyme, using benzoylcholine s Substrate and dibucaine s differential inhibitor. In conclusion, the evaluated procedure not only has the advantage of being continuous, colorimetric and totally enzymatic but also appears to be accurate, precise and relatively simple to perform; its satisfactory performance is indicated by the good agreement between the results of the assay kit and the three reference methods. Finally, this procedure appears to be applicable to several different type of automatic analysers.
